Parametric Portfolio Associates LLC acquired a new position in shares of Rafael Holdings Inc (NYSEAMERICAN:RFL) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 8,839 shares of the company’s stock, valued at approximately $254,000. Parametric Portfolio Associates LLC owned about 0.06% of Rafael as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of RFL. Aperio Group LLC bought a new stake in shares of Rafael in the 2nd quarter valued at about $29,000. Kahn Brothers Group Inc. DE grew its position in shares of Rafael by 38.4% in the 2nd quarter. Kahn Brothers Group Inc. DE now owns 431,921 shares of the company’s stock valued at $12,418,000 after buying an additional 119,886 shares during the last quarter. Wells Fargo & Company MN grew its position in shares of Rafael by 663.8% in the 2nd quarter. Wells Fargo & Company MN now owns 9,990 shares of the company’s stock valued at $287,000 after buying an additional 8,682 shares during the last quarter. Bank of Montreal Can grew its position in shares of Rafael by 342.1% in the 2nd quarter. Bank of Montreal Can now owns 1,008 shares of the company’s stock valued at $29,000 after buying an additional 780 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. bought a new stake in shares of Rafael in the 2nd quarter valued at about $724,000.
Shares of NYSEAMERICAN:RFL traded up $0.03 during midday trading on Friday, reaching $16.32. The company’s stock had a trading volume of 10,490 shares, compared to its average volume of 49,665. Rafael Holdings Inc has a fifty-two week low of $6.90 and a fifty-two week high of $30.86.
Rafael (NYSEAMERICAN:RFL) last announced its quarterly earnings data on Thursday, October 3rd. The company reported ($0.16) earnings per share (EPS) for the quarter. The firm had revenue of $1.40 million during the quarter.
Rafael Company Profile
Rafael Holdings, Inc holds commercial real estate assets. The company, through its subsidiaries, engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael Holdings, Inc is headquartered in Newark, New Jersey.
Receive News & Ratings for Rafael Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rafael and related companies with MarketBeat.com's FREE daily email newsletter.